MEDDIC: why most B2B teams qualify deals wrong

The deal was green on every field. I was sitting in a Thursday forecast call with a Series B company, and the rep walked us through a $180K opportunity that had all six MEDDIC boxes ticked in the CRM. Metrics, filled. Economic buyer, filled. Champion, filled. Decision process, filled. The forecast called it "commit." Two weeks later it slipped to next quarter. Two weeks after that it was dead. When we pulled the recording, the "economic buyer" turned out to be a director who had never controlled the budget, and the "champion" was a friendly analyst who liked the demo and had zero power to spend a dollar. Every field was filled. Not one of them was true.

That deal is the whole problem with MEDDIC in one story. The framework is not the issue. MEDDIC is probably the best B2B qualification tool ever written, and roughly 73% of SaaS companies selling above $100K ARR run some version of it. The issue is that most teams treat it as a set of boxes to tick so the deal can move stages, when it was built as a live read on whether you are actually going to win. Ticked boxes and truth are two different things, and the gap between them is where forecasts go to die.

I have rolled MEDDIC out at a handful of companies and cleaned up failed rollouts at a few more. This is what I have learned about making it actually change deals instead of just adding CRM fields nobody trusts.

What MEDDIC actually stands for

Quick refresher, because half the teams using it cannot recite it cleanly. MEDDIC is six things you have to know to call a deal real.

Metrics: the quantified economic outcome the buyer gets, in their numbers, not yours. Economic buyer: the person who controls the money and can say yes on their own. Decision criteria: the specific standards the buyer will use to choose, technical and business and financial. Decision process: the actual steps and dates the buyer will move through to buy, including who signs. Identify pain: the compelling reason to change now, not someday. Champion: a person with power who sells for you when you are not in the room.

MEDDPICC adds two more for bigger deals: Paper process, the legal, security, and procurement steps that quietly add six weeks to a close, and Competition, which includes the incumbent and the status quo, not just other vendors. The rule I use is simple. Deals over $100K with five or more stakeholders and a multi-month cycle get the full MEDDPICC. A 45-day mid-market deal gets MEDDIC or even plain qualification, because forcing eight fields onto a small deal is how you teach reps to hate the framework and fill it with fiction.

Why MEDDIC fails in most teams

Here is the thing nobody selling you a methodology course will say plainly: MEDDIC failure is almost never a knowledge problem. Your reps can pass the quiz. It fails because of how it gets operated, and the failure modes are boringly consistent.

The most common one is treating it as a stage gate you clear once instead of a read you keep taking. A rep fills the fields when the deal is created, moves it to the next stage, and never touches them again. Six weeks later the deal has changed completely, a new stakeholder appeared, the budget got frozen, but the scorecard still says what it said in week one. Managers then read those stale fields back in pipeline review like scripture, and everyone nods at a number that describes a deal that no longer exists.

The second is scoring from opinion instead of evidence. "Champion: yes" should mean a specific human did a specific thing that proves they will spend political capital for you. Not that the rep has a good feeling. A field is only met when the buyer's own words or actions prove it. Every other case is a guess wearing a green checkmark. I tell reps: if you cannot point to the email, the call moment, or the action that proves the field, the field is empty. Write it as empty.

The third, and the one that killed my $180K deal, is confusing a coach with a champion, and skipping the economic buyer because the coach is nice to you. A coach gives you information. A champion has power and uses it on your behalf. They are not the same person and mistaking one for the other is how a fully-qualified-looking deal collapses the moment you leave the room. Most enterprise deals that die were single-threaded through one friendly contact who could not actually approve anything.

The three letters that decide most deals

All six letters matter, but after enough forecast calls I can tell you the ones that actually separate deals that close from deals that lie to you. If you only get three right, get these three.

The way you test a champion is the single most useful habit in the whole framework. Stop asking your contact for information and start asking them for action. "Can you get me 20 minutes with the VP who owns the budget?" A real champion makes it happen. A coach gives you a reason it is hard right now. That one request tells you more about whether you will win than every green field on the scorecard combined.

Run it as a rhythm, not a form

The teams that get real value out of MEDDIC do one thing differently. They treat it as an operating rhythm that lives in every deal review, not a form reps fill after a call. The numbers back this up. Teams that adopt MEDDIC well report 20 to 30% higher close rates and around 40% more accurate forecasting, and full MEDDPICC adopters see roughly 18% higher win rates and 24% larger deals. But those numbers belong to teams that operate it. The teams that just added the fields see nothing, because a scorecard nobody interrogates is just extra typing.

Here is how I set the rhythm up. Front-load the discovery. Most of MEDDIC gets answered in the first two or three conversations if the rep is asking the right questions, which is why a strong discovery call motion matters more than the scorecard itself. Pain and metrics come first, because if there is no compelling reason to change now, the rest is academic.

Then, in every pipeline review, the manager does not ask "how's this deal looking." They ask for the evidence behind two or three specific letters. "Show me what the champion did last week." "Who is the economic buyer and when did we last talk to them." "What is the actual metric in their numbers." When reps know that question is coming, they stop guessing and start gathering proof, because they have to defend the field out loud. That is the entire mechanism. The framework does not coach reps. The conversation about the framework coaches reps.

And you have to let deals be red. A scorecard where everything is green is a scorecard nobody trusts. The point of MEDDIC is to surface what you do not know while you still have time to fix it. A rep who marks "economic buyer: unknown" in week two is doing the job right. A rep who marks it "confirmed" from a hopeful assumption is setting up the exact forecast miss I opened this piece with.

Where it plugs into your CRM and forecast

MEDDIC lives or dies on whether it is wired into how you already run the pipeline, or bolted on as a separate ritual. Bolt it on and it becomes homework. Wire it in and it becomes the read.

The practical build is to make the MEDDIC fields part of your stage definitions, so a deal cannot move to a late stage without the evidence that stage requires. This is the same discipline as defining your pipeline stages by the buyer rather than by internal milestones. Proposal stage should require a confirmed economic buyer and a tested champion, full stop. If those are empty, the deal is not in proposal no matter how much the rep wants it there. That single rule does more for forecast accuracy than any dashboard, because it stops deals from sitting in late stages on hope.

The failure I see most often here is the CRM adoption gap. Reps backfill MEDDIC fields from memory after calls, badly, because they see the fields as compliance rather than a tool that helps them win. That is a real problem and it is the same one behind most bad CRM data. If your team will not update the fields honestly, you have a CRM adoption problem to fix before MEDDIC will do anything, and no methodology survives contact with data reps do not trust. We do a lot of this wiring as part of our CRM and RevOps work, because the framework is only as good as the system it runs on.

There is also a real role for AI here now, and it is genuinely useful when it is aimed right. A call recording tool that listens to a discovery call and drafts the MEDDIC fields from what the buyer actually said, so the rep edits and confirms instead of inventing from memory, attacks the exact honesty problem that breaks most rollouts. We build these kinds of AI automation layers so the evidence gets captured at the source. What AI cannot do is decide whether your champion has real power. That judgment stays human, and it is the judgment that wins deals.

When MEDDIC is the wrong tool

Let me push back on my own methodology for a second, because the honest answer matters. MEDDIC is built for complex, considered, higher-value B2B deals with multiple stakeholders. If you sell a $6K annual product on a two-call cycle to a single buyer with a credit card, running full MEDDIC on it is malpractice. You will slow the deal down and annoy everyone for no forecast benefit.

For those motions, a lighter qualification is fine, and the discipline you actually want is speed and consistency, not depth. The skill is matching the framework to the deal. Big, multi-threaded, board-visible deals get MEDDPICC. Mid-market gets MEDDIC. Transactional gets a two-line qualification and a fast path. A team that runs the same heavy process on every deal is as broken as a team that runs none, and both show up the same way in your sales forecast: a number nobody believes.

FAQ

What does MEDDIC stand for in sales?

MEDDIC stands for Metrics, Economic buyer, Decision criteria, Decision process, Identify pain, and Champion. It is a B2B sales qualification framework that defines the six things a rep has to know, with evidence, to call a deal genuinely winnable. MEDDPICC adds Paper process and Competition for larger, more complex deals.

What is the difference between MEDDIC and MEDDPICC?

MEDDPICC is MEDDIC plus two elements: Paper process, which covers the legal, security, and procurement steps needed to close, and Competition, which includes rival vendors and the status quo. Use MEDDPICC for deals over $100K with five or more stakeholders and multi-month cycles. Smaller or faster deals do fine with MEDDIC, and forcing the heavier version on them just creates paperwork reps resent.

Why does MEDDIC fail for so many teams?

It usually fails on operation, not knowledge. Teams treat it as a one-time stage gate instead of a live read, score fields from opinion instead of evidence, and confuse a friendly coach with a champion who has real power. The fix is to re-check the fields in every deal review, demand evidence for each one, and test the champion by asking them to take an action rather than just share information.

How is a champion different from a coach in MEDDIC?

A coach gives you information and inside context but has no power to move the decision or the budget. A champion has real influence and spends it on your behalf, selling internally when you are not in the room. The test is action: ask your contact to set up the economic buyer meeting or share the internal decision criteria. A champion does it. A coach explains why it is hard right now.

Is MEDDIC worth it for a small B2B company?

Yes, if your deals are considered purchases with multiple stakeholders, even at low volume. The value is forecast accuracy and fewer late-stage surprises, which matter as much at 40 people as at 400. But keep it proportional. Run MEDDIC on your real, complex deals and use light qualification on small transactional ones, so the framework helps reps win instead of becoming busywork they route around.